David S. Rickman
- Weill Cornell Medicine · Pathology (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #11,973
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9368172Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-7420-5883Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Urology
- Pathology
NIH Funding · FY2025
Linked Award Amount
$1.3M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#11,973
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing David S. Rickman as a PI. Multi-PI records show the full award amount for context.
- 1R01CA301637-01R01Co-investigatorThe role of early oncogenic drivers in maintaining lineage fidelity in prostate cancerWeill Cornell Medicine · Urology (NIH department code)$684Kaward amount
- 5R01CA274963-03R01Contact PI"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"Weill Cornell Medicine · Pathology (NIH department code)$645.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing David S. Rickman as a PI.
FY2025 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWeill Cornell Medicine
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as David S. Rickman.